{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T08:43:36Z","timestamp":1782809016818,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To determine the likelihood of obtaining at least one transferable embryo per cycle in patients undergoing IVF with PGT-A\u2009+\u2009PGT-M for variants in one versus two genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>IVF cycles in patients 18\u201345\u00a0years undergoing PGT-A\u2009+\u2009PGT-M for variants in one or two genes at a single genetics laboratory were analyzed from 11\/2019 to 3\/2023. Cycles were stratified by SART age category and disease inheritance pattern. Analyses were performed using median and chi-square tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 4634 IVF cycles were included: 146 cycles (3.15%) using PGT-A\u2009+\u2009PGT-M for two genes and 4488 cycles (96.85%) for one gene. After adjusting for the number of embryos biopsied, the likelihood of having at least one usable embryo was significantly lower in patients testing for variants in two genes compared to one in patients aged\u2009&lt;\u200935 (75.0% v 82.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004) and 35\u201337 (55.0% v 74.4%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.025) with no difference in other age groups 38\u201340 (66.7% v 74.4%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.586) and 41\u201342 (42.9% v 51.7%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.113).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There were significantly lower odds of obtaining a usable embryo when testing for variants in genes in patients aged\u2009&lt;\u200935 and 35\u201337. No significant difference was seen among patients aged 38\u201340 or 41\u201342. These findings provide quantifiable data to counsel patients considering PGT-M testing for variants in two genes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10815-026-03868-4","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T01:50:59Z","timestamp":1776995459000},"page":"1749-1755","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Likelihood of obtaining a usable embryo for transfer after IVF with PGT-A and PGT-M for variants in two genes"],"prefix":"10.1007","volume":"43","author":[{"given":"Melody A.","family":"Rasouli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnaz","family":"Siavoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Woody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Kroener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"3868_CR1","doi-asserted-by":"publisher","unstructured":"Parikh T, Goti A, Yashi K, et al (2023) Pediatric sickle cell disease and stroke: a literature review. Cureus 15: https:\/\/doi.org\/10.7759\/CUREUS.34003","DOI":"10.7759\/CUREUS.34003"},{"key":"3868_CR2","doi-asserted-by":"publisher","unstructured":"Romero S, Rink B, Biggio Jr JR, Saller Jr DN (2017) Carrier screening in the age of genomic medicine. Obstetrics and Gynecology 129:e35\u2013e40. https:\/\/doi.org\/10.1097\/AOG.0000000000001951","DOI":"10.1097\/AOG.0000000000001951"},{"key":"3868_CR3","doi-asserted-by":"publisher","unstructured":"Perinatal Palliative Care: ACOG Committee Opinion Summary, Number 786 (2019) Obstetrics and Gynecology 134(3):660\u2013661. https:\/\/doi.org\/10.1097\/AOG.0000000000003426","DOI":"10.1097\/AOG.0000000000003426"},{"key":"3868_CR4","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/s41436-021-01203-z","volume":"23","author":"AR Gregg","year":"2021","unstructured":"Gregg AR, Aarabi M, Klugman S, et al. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23:1793\u2013806. https:\/\/doi.org\/10.1038\/s41436-021-01203-z.","journal-title":"Genet Med"},{"key":"3868_CR5","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/JGC4.1676","volume":"32","author":"KG Sagaser","year":"2023","unstructured":"Sagaser KG, Malinowski J, Westerfield L, et al. Expanded carrier screening for reproductive risk assessment: an evidence-based practice guideline from the National Society of Genetic Counselors. J Genet Couns. 2023;32:540\u201357. https:\/\/doi.org\/10.1002\/JGC4.1676.","journal-title":"J Genet Couns"},{"key":"3868_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17832","volume":"131","author":"J Elson","year":"2024","unstructured":"Elson J, Drakeley A, Achilli C, et al. The use of expanded carrier screening in reproductive medicine: scientific impact paper no. 74. BJOG. 2024;131:e81. https:\/\/doi.org\/10.1111\/1471-0528.17832.","journal-title":"BJOG"},{"key":"3868_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2022.09.286","volume":"118","author":"J Buldo-Licciardi","year":"2022","unstructured":"Buldo-Licciardi J, Shaw J, Besser AM, Blakemore J. Trends in preimplantation genetic testing for double monogenic disorders (PGT-M). Fertil Steril. 2022;118:e38. https:\/\/doi.org\/10.1016\/j.fertnstert.2022.09.286.","journal-title":"Fertil Steril"},{"key":"3868_CR8","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/J.FERTNSTERT.2024.07.030","volume":"122","author":"RA Martel","year":"2024","unstructured":"Martel RA, Lee MB, Schadwell A, et al. Aneuploidy rates and likelihood of obtaining a usable embryo for transfer among in vitro fertilization cycles using preimplantation genetic testing for monogenic disorders and aneuploidy compared with in vitro fertilization cycles using preimplantation genetic testing for aneuploidy alone. Fertil Steril. 2024;122:993\u20131001. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2024.07.030.","journal-title":"Fertil Steril"},{"key":"3868_CR9","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.fertnstert.2020.11.041","volume":"115","author":"M Viotti","year":"2021","unstructured":"Viotti M, Victor AR, Barnes FL, et al. Using outcome data from one thousand mosaic embryo transfers to formulate an embryo ranking system for clinical use. Fertil Steril. 2021;115:1212\u201324. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.11.041.","journal-title":"Fertil Steril"},{"key":"3868_CR10","first-page":"2043","volume":"39","author":"E Stocker","year":"2022","unstructured":"Stocker E, Johal S, Rippel L, Darrah R. Frequency of embryos appropriate for transfer following preimplantation genetic testing for monogenic disease. JARG. 2022;39:2043\u201350.","journal-title":"JARG"},{"key":"3868_CR11","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1093\/HUMREP\/DEX215","volume":"32","author":"MG Minasi","year":"2017","unstructured":"Minasi MG, Fiorentino F, Ruberti A, et al. Genetic diseases and aneuploidies can be detected with a single blastocyst biopsy: a successful clinical approach. Hum Reprod. 2017;32:1770\u20137. https:\/\/doi.org\/10.1093\/HUMREP\/DEX215.","journal-title":"Hum Reprod"},{"key":"3868_CR12","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/S10897-016-9975-4","volume":"25","author":"KN Goldman","year":"2016","unstructured":"Goldman KN, Nazem T, Berkeley A, et al. Preimplantation genetic diagnosis (PGD) for monogenic disorders: the value of concurrent aneuploidy screening. J Genet Couns. 2016;25:1327\u201337. https:\/\/doi.org\/10.1007\/S10897-016-9975-4.","journal-title":"J Genet Couns"},{"key":"3868_CR13","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/S10815-022-02571-4","volume":"39","author":"E Stocker","year":"2022","unstructured":"Stocker E, Johal S, Rippel L, Darrah R. Frequency of embryos appropriate for transfer following preimplantation genetic testing for monogenic disease. J Assist Reprod Genet. 2022;39:2043. https:\/\/doi.org\/10.1007\/S10815-022-02571-4.","journal-title":"J Assist Reprod Genet"},{"key":"3868_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/GENES11060692","volume":"11","author":"PM Pardo","year":"2020","unstructured":"Pardo PM, Mart\u00ednez-conejero JA, Mart\u00edn J, et al. Combined preimplantation genetic testing for autosomal dominant polycystic kidney disease: consequences for embryos available for transfer. Genes 2020, Vol 11, Page 692. 2020;11:692. https:\/\/doi.org\/10.3390\/GENES11060692.","journal-title":"Genes 2020, Vol 11, Page 692"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-026-03868-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-026-03868-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-026-03868-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:44:19Z","timestamp":1782805459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-026-03868-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["3868"],"URL":"https:\/\/doi.org\/10.1007\/s10815-026-03868-4","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data received from the genetic laboratory were de-identified, and thus, the study was deemed exempt by the University of California Los Angeles Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.A.R has nothing to disclose. L.C. has nothing to disclose. M.B.L. has nothing to disclose. R.M. has nothing to disclose. M.S. has nothing to disclose. L.K. has nothing to disclose. J.M. reports employment at Cooper Genomics, CooperSurgical preimplantation genetic testing laboratory; data for analysis provided by the preimplantation genetic testing laboratory; honoraria from Yosan University, New England Fertility Society; and Eastern Virginia Medical School Embryology Graduate Program; Genetic Counseling Professional Group, board member 2020\u2013Present, chair 2022\u20132023. C.W. reports employment at Cooper Genomics. R.A.R. has nothing to disclose. L.K. is a board member of Pacific Coast Reproductive Society and Rooting for Robert.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}